NEW YORK (GenomeWeb News) – Bio-Reference Laboratories today reported that its first quarter revenues grew 12 percent, as the firm noted plans to expand its GeneDx business.

The Elmwood Park, NJ-based clinical lab firm reported revenues of $181.3 million for the three months ended January 31, up from $161.3 million for the first quarter of 2013. It beat the consensus Wall Street estimate of $171.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Even when given the option, not too many authors choose double-blinded peer-review for their manuscripts, ScienceInsider reports.

In PNAS this week: transcriptional read-through in stressed cells, genome stability role for the epigenetic regulator CTCF, and more.

The Save the Redwoods League is teaming with researchers to sequence the genomes of the coast redwood and giant sequoia.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.